Eric Painbeni

Affiliations

Drug Development Unit (DDU), STALICLA SA, Campus Biotech Innovation Park, Avenue de Sécheron 15, 1202 Geneva, Switzerland.

Publications (1)

Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD.

Biomedicines

Avec: Craig A Erickson , Laura Perez-Cano , Ernest V Pedapati , Eric Painbeni , Gregory Bonfils , Lauren M Schmitt , Hannah Sachs , Meredith Nelson , Lisa De Stefano , Grace Westerkamp , Adriano L S de Souza , Oliver Pohl , Offir Laufer , Gil Issachar , Thomas Blaettler , Jean-Marc Hyvelin , Lynn A Durham

Réseau de co-auteurs

Craig A Erickson 1 collaboration

Laura Perez-Cano 1 collaboration

Ernest V Pedapati 1 collaboration

Gregory Bonfils 1 collaboration

Lauren M Schmitt 1 collaboration

Hannah Sachs 1 collaboration

Meredith Nelson 1 collaboration

Lisa De Stefano 1 collaboration

Grace Westerkamp 1 collaboration

Adriano L S de Souza 1 collaboration

Oliver Pohl 1 collaboration

Offir Laufer 1 collaboration

Gil Issachar 1 collaboration

Thomas Blaettler 1 collaboration

Jean-Marc Hyvelin 1 collaboration

Lynn A Durham 1 collaboration